---
document_datetime: 2023-09-21 17:11:55
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ioa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: ioa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.0616179
conversion_datetime: 2025-12-24 15:06:07.480853
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

<!-- image -->

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                                                                                           | Opinion/ Notification 1 issued on Commission Decision Issued amended on no   | 2 / Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|--------------------------------------|-----------|
| IA/0013/G            | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or product | 02/05/2014                                                                   | n/a                                  |           |

<!-- image -->

Ioa Procedural steps taken and scientific information after the authorisation 1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures. 2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact Medicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

|          | intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                                                                           |            |            |                                  |                                                                     |
|----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------|
| A31/0007 | Pursuant to Article 31 of Directive 2001/83/EC, review of the benefit-risk balance of combined hormonal contraceptives containing chlormadinone, desogestrel, dienogest, drospirenone, etonogestrel, gestodene, nomegestrol, norelgestromin or norgestimate at the request of the French medicines agency (ANSM) following concerns about the risk of venous thromboembolism. | 21/11/2013 | 16/01/2014 | SmPC and PL                      | Please refer to the assessment report: EMEA/H/A-31/1356/C/2068/0007 |
| IB/0010  | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                 | 15/11/2013 | n/a        | longer                           |                                                                     |
| IG/0366  | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location product                                                                                                                                                                                                       | 08/11/2013 | n/a no     |                                  |                                                                     |
| IB/0009  | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                 | 16/10/2013 |            | SmPC, Annex II, Labelling and PL |                                                                     |
| T/0008   | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                           | 22/07/2013 | 14/08/2013 | SmPC, Labelling and PL           |                                                                     |
| N/0006   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                              | 03/12/2012 |            | PL                               |                                                                     |

Medicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

| IG/0184   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 21/08/2012   | n/a        |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|
| IB/0003   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 09/03/2012   | n/a        |
| N/0004    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 29/02/2012   | n/a PL     |
| IG/0138   | B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 02/02/2012   | n/a longer |
| IG/0126/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.g - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the site undertaking pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system product | 14/12/2011   | n/a no     |

<!-- image -->

Medicinal product no longer authorised